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Yan-mei Liu1 and Sha Zhao1*Abstract
Aggressive natural killer cell leukemia/lymphoma (ANKL) is a rare aggressive form of NK-cell neoplasm. We report an
uncommon case of 36-year-old male who showed jaundice and spontaneous splenic rupture. The diagnosis was
established by the biopsy of liver and spleen. The monomorphous medium-size neoplastic cells infiltrated into
portal areas and sinus of liver as well as the cords and sinus of the spleen. Necrosis, mitotic figures and significant
apoptosis could be seen easily. These neoplastic cells demonstrated a typical immunophenotype of CD3ε+, CD56+,
CD16+, Granzyme B+, TIA-1+. T-cell receptor γ (TCR-γ) gene rearrangement analysis showed germline configuration
and the result of in situ hybridization for Epstein-Barr virus-encoded RNA (EBER-ISH) was positive. The patient has
undergone an aggressive clinical course and died of multi-organ function failure 14 days later after admission. To
the best of our knowledge, this is the first case of ANKL with spontaneous splenic rupture, and we should pay
more attention to recognize it.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2048154883890867
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Aggressive natural killer cell leukemia/lymphoma (ANKL)
is a rare neoplasm which comprises less than 0.1% of all
lymphoid neoplasms [1]. Different from the usual leukemia,
the neoplastic cells in ANKL can be sparse in peripheral
blood and bone marrow [2]. From our review of relevant
literature, the patient we reported is the first case of ANKL
with spontaneous splenic rupture as the initial symptom.Case presentation
Case report
A 36-year-old man had presented with jaundice and pain
of abdomen for 5 days. The patient seemed to get a cold
5 days ago before he was sent to hospital, then a serious
jaundice of general skin appeared, accompanying with a
bursting pain on the middle abdomen, which was* Correspondence: liuweiping2001@vip.sina.com; HXBLZHAOSHA@126.com
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reproduction in any medium, provided the orpersistent without reflection. There were some other
symptoms such as nausea, chest tightness, muscle weak-
ness and anorexia. The second day after admission, the
patient had a significant pain on the upper abdomen,
with rebound tenderness. Physical examination showed
no palpable superficial lymph nodes. His abdomen was
soft, while light tenderness was presented in the upper
abdomen without rebound tenderness. The liver was
palpable below the right costal margin, but the spleen was
impalpable. Laboratory tests demonstrated (1) White blood
cells 4.60 × 109/L (neutrophil 84.7%, lymphocyte 10.3%, no
abnormal cells had been found), red blood cells 3.87 ×
1012 L, platelets 64 × 109/L. hemoglobin 140 g/L (2) Total
bilirubin 340.5 umol/L, direct bilirubin 281.0 umol/L, as-
partate aminotransferase 1163 U/L, glutamic-oxal(o) acetic
transaminase 1765 U/L, lactate dehydrogenase 1253 IU/L,
total bile acid 109.4 umol/L.(3) Prothrombin time 27.2 s,
activated partial thromboplastin time 43.8 s, fibrinogen
1.36 g/L, thrombin time 26.4 s. Computer tomography
scans revealed hepatosplenomegaly; hemorrhage was. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gest hematoma was located under the spleen and the max-
imum cross-sectional area of which was 9.5 cm × 4.3 cm;
ascites and enlarged lymph nodes of peritoneal cavity were
also noted. [Figure 1(A, B)] Splenic rupture was diagnosed
by CT scans. Splenectomy was performed immediately and
the biopsy of liver was implemented simultaneously.Figure 1 Hepatosplenic CT images and histopathology. (A, B) CT scan
parenchymal and perisplenic (arrow), the largest hematoma was located unde
9.5 cm× 4.3 cm; ascites and enlarged lymph nodes of peritoneal cavity were
and sinusoidal infiltration (arrow) (H&E, original magnification × 40). (D) Neopl
nuclei. Mitotic figures and apoptosis can be easily seen (H&E, original magnific
and sinuses of red pulp, as well as around arteriolar sheath (H&E, original mag
medium sized (H & E, original magnification × 400). (G) Necrotic areas were se
blood vessel infiltration phenomenon was observed in the spleen (arrow) (H &Pathologic findings
Macroscopically, a small piece of tissue was taken from
the liver for biopsy and the volume was 1.5 cm × 0.8 cm ×
0.6 cm. It was grey-brown in color with smooth capsule.
Spleen was dissected completely with 19.0 cm × 12.5 cm ×
7.0 cm in volume and 870.0 gram in weight. The capsule
of splenic hilum was absent and lots of blood clots weredemonstrated hepatosplenomegaly; hemorrhage was observed in splenic
r the spleen and the maximum cross-sectional area of which was
also noted. (C) Histologic examination of liver showed the portal areas
astic cells in the liver were monomorphic and medium size with irregular
ation × 400). (E) Neoplastic cells in the spleen were observed in cords
nification × 40). (F) Neoplastic cells in the spleen were monomorphic and
en in the spleen (arrow) (H & E, original magnification × 40). (H) The
E, original magnification × 264).
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was observed after the spleen was cut in slices. Micro-
scopically, the normal structure of the liver was partly
damaged, and many monomorphic medium-sized cells
infiltrated into portal areas and sinusoids, with thin to
moderate rim of pale or amphophilic cytoplasm, irregu-
lar nuclei, slightly condensed chromatin and incon-
spicuous nucleoli. Mitotic figures and apoptosis were
obvious in these areas [Figure 1(C, D)]. The sections
from the spleen showed expansion of the red pulp with
relative depletion of the white pulp. Neoplastic cells were
found in the cords and sinuses of red pulp, as well as
around splenic arteriolar sheath. The morphology and size
of tumor cells were similar to which infiltrated into the
liver [Figure 1(E, F)]. Necrosis and the blood vessel infil-
tration phenomenon could be observed in the spleen
[Figure 1(G, H)]. Immunohistochemically, the neoplastic
cells were CD3ε+, CD56+, CD16+, CD43+, Granzyme B+,Figure 2 Immunohistochemistry staining of the hepatic tissue and sp
original magnification × 400), negative for CD20 (B, liver; J, spleen. original
K, spleen. original magnification × 400), CD16 (D, liver; L, spleen. original m
magnification × 400), TIA-1 (F, liver; N, spleen. original magnification × 400).
magnification × 200). The result of EBER-ISH was positive (H, liver; P, spleenTIA-1+, CD20-, CD2-, CD5-, CD7-, CD4-, CD8- and
CD123-. The proliferation index was approximately 90%,
assessed by Ki-67 staining and the result of EBER-ISH
showed positive for most of the abnormal cells (Figure 2).
No obvious band of cloned TCR-γ gene rearrangement
was detected by the Polymerase Chain Reaction heterodu-
plex analysis (PCR-HA) and polyacrylamide gel electro-
phoresis (PAGE) (Figure 3). Combined with morphology
and the result of immunohistochemistry, TCR-γ gene re-
arrangement analysis and in situ hybridization, the final
diagnosis was made as aggressive natural killer cell
leukemia/lymphoma (ANKL).
Follow up
The patient has undergone an aggressive clinical course
and developed into multiple organ dysfunction syndromes
(MODS) in a short time. The patient died of multi-organ
function failure 14 days later after hospitalization. Withoutlenic tissue. The tumor cells were positive for CD3ε (A, liver; I, spleen.
magnification × 400), and they were positive for CD56 (C, liver;
agnification × 400) Granzyme B (E, liver; M, spleen. original
, the Ki-67 index was about 90% G, liver; O, spleen. original
. original magnification × 400).
Figure 3 Polymerase Chain Reaction heteroduplex analysis. No
obvious band of cloned TCR-γ gene rearrangement was detected
PCR-HA (A, B),(M, maker; p, positive control; B, blank; N, negative
control; 1, liver; 2, spleen; HA, heteroduplex analysis; C1, internal
control of liver; C2, internal control of spleen).
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performed.
Discussion
ANKL is a rare form of neoplasm characterized by a sys-
temic proliferation of NK cells with an aggressive clinical
course. It is originally recognized in the mid-1980s as a
non-T-cell type of aggressive large granular lymphocyte
(LGL) leukemia [3]. This disease has a higher incidence
in Asians compared with other ethnic populations. Most
of the patients are young people, with a median age of
42 years old, men and women are equally affected or
men have a slight predominance [4]. NK neoplastic cells
are almost invariably infected with Epstein-Barr virus
(EBV), and it is suggesting that the virus may be of
pathogenetic significance [5]. ANKL mainly involved in
bone marrow and peripheral blood, as well as liver and/
or spleen. Skin involvement is rare. Patients are typically
very ill with fever, anemia, thrombocytopenia, dissemi-
nated intravascular coagulation (DIC) and liver function
disturbances [5,6]. High levels of serum lactate dehydro-
genase can also be found in the serum. Liver function
derangement, disseminated intravascular coagulopathy
and multiorgan failure appear progressively and most
patients die within days to weeks after presentation, with
a median survival of 2 months [1].
About 150 cases have been reported in the literature and
the largest series is 22 cases analyzed by R Suzuki, et al. [3].
Among those cases, 107 (71%) with spleen involvement
and 109 (72%) with liver involvement. Major clinical mani-
festations included hepatosplenomegaly, jaundice and liver
function disturbances, while there is no report of splenic
rupture. So our case is the first report of ANKL complicat-
ing with spontaneous splenic rupture. The patient we re-
port is 36 years old and the main symptoms are sudden
jaundice and hepatosplenomegaly. The unique feature in
this case is its presentation as spontaneous (pathologic)splenic rupture. The mainly possible causes of spontaneous
splenic rupture in this kind of leukemia are suspected as
follows: 1. Most commonly, malignant cells infiltrate into
the spleen directly and their sheer volume exceeds the cap-
acity of the relatively nondistensible splenic capsule, caus-
ing capsular rupture, and splenic hemorrhage. 2. Splenic
infarction with vascular invasion, consequent subcapsular
hemorrhage and subsequent rupture of splenic capsule. 3.
Coagulation disturbance related to the disease [7]. This
reported case highlights the importance of considering
diagnosis of ANKL in patients presenting with jaundice,
massive hepatosplenomegaly and the possibility of splenic
rupture.
As reported, different from the usual leukemia, the
leukemia cells of ANKL constitute less than 5% to more
than 80% of lymphocytes in the peripheral blood, and
account for 6% to 92% of nucleated cells in the bone mar-
row [2], so it is appropriate to term this neoplasm as
“leukemia/lymphoma” [2]. In most reported cases in the
literature, the diagnosis of ANKL is based on the result of
bone marrow aspiration and/or the peripheral blood
smear, and it is seldom mentioned on the biopsies on the
liver and spleen [8]. However, as we all known the charac-
teristic of this leukemia is that the neoplastic cells in
ANKL can be sparse in peripheral blood and bone mar-
row, so the ANKL can be diagnosed by neoplastic cells
existing in spleen and liver without the evidence in the
peripheral blood and/or bone marrow. Our reported case
has some features as following: First, the patient has
showed a highly aggressive clinical course with massive
hepatosplenomegaly, splenic rupture, coagulation disor-
ders and short survival time, no history of other disease.
Then a diffuse and destructive infiltration of monomorph-
ous neoplastic cells was observed in histologic sections of
liver and spleen, which are medium in size, with few to
moderate cytoplasm and irregular nuclei. Nuclei showed
slightly condensed chromatin pattern and inconspicuous
or distinct nucleoli. Necrosis, mitotic figures and signifi-
cant apoptosis could be seen easily. Additionally, these
neoplastic cells demonstrated a typical immunophenotype
of CD3ε+, CD56+, CD16+, Granzyme B+, TIA-1+, CD43+.
T-cell receptor γ (TCR-γ) gene rearrangement analysis
showed germline configuration and the result of EBER1/2-
ISH was positive. From above, this case was coincided with
the pathologic diagnostic criteria for ANKL compared with
previously reported cases [4,9,10]. Unfortunately, bone
marrow biopsy and marrow smear of this patient had not
been performed but the diagnosis of ANKL was still
established according to the evidence of the biopsy of liver
and spleen, clinical features and laboratory findings.
Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-
N) with advanced stage is also a highly aggressive neo-
plasm with a dismal clinical outcome, yet the relationship
and boundary between ENKTCL-N with advanced stage
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ities between ENKTCL-N with advanced stage and ANKL,
such as the morphology, immunophenotype, germline
configuration of TCR gene and EBV association. However,
Kwong, Y. L., et al. has pointed out ANKL can be different
from ENKTCL-N by the absence of a previous history, a
shorter illness, a younger age of presentation and an ex-
tremely aggressive course [5]. A recent array-based com-
parative genomic hybridization study indicates that loss of
7p and 17p and gain of 1q are frequent in ANKL which are
different from ENKTCL-N [11], but the genetic changes
still need to be proven by large amount case–control study.
ANKL Involving the liver and spleen can mimic the
hepatosplenic T cell lymphoma which also presents jaun-
dice and massive hepatosplenomegaly, but the neoplatic
cells in hepatosplenic T cell lymphomas are commomly ob-
served in sinus, and express T-cell makers, have rearranged
TCR gene, and have no relatetion with EBV infection.
Systemic Epestein-Barr virus positive T-cell lympho-
proliferative disease and ANKL also have some similar-
ities: the fulminant clinical manifestations, presence of
EBV in proliferating cells, and systemic hemopha-
gocytosis. However, systemic EBV+ T-cell LPD is more
common in children and monoclonal for T-cell recep-
tor gene rearangement [2].
Plasmacytoid dendritic cell leukemia (pDCL) is a rare
leukemia and needs to be identified with ANKL. Clinically,
pDCL usually present an isolated cutaneous lesion at the
time of diagnosis and rapidly evolves to multiple sites, pro-
liferates into the blood, bone marrow, lymph nodes and
other areas such as the spleen, liver, central nervous sys-
tem (CNS),. Although expression of CD56, CD2, CD7 or
granzyme B can be common between pDCL and ANKL,
However, pDCL can be identified by the following pheno-
type: CD4±, high expression of CD123 (IL-3α receptor),
BDCA-2 ± (blood dendritic cell antigen-2 or CD303±),
BDCA-4 ± (CD304±), and it is not associated with EBV in-
fection [12,13].
For other differential diagnosis, T cell lymphomas, such
as peripheral T-cell lymphoma, not otherwise specified
(PTCL-NOS) and anaplastic large cell lymphoma (ALCL)
are also need to be considered. When tumor infiltrate into
liver and spleen, clinical symptoms are similar with ANKL.
Jaundice and massive hepatosplenomegaly are also can be
seen. Meanwhile, morphologically, middle to large-sized
neoplastic cells with atypia and mitosis can be detected in
T cell lymphoma and ANKL. However, as previously
mentioned, the characteristic T-cell makers, rearranged
TCR gene, and have no relation to EBV infection are
distinguishing features [14,15].
Conclusion
This is the first case of ANKL with jaundice and spon-
taneous splenic rupture, which is hard to be diagnosedand easily confused with some other diseases. We should
accumulate much experience to recognize it and treat it
with effective methods for its fulminant clinical course.
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